Spectral Announces Appointment of Dr. Masayuki Kaneko to Its Board of Directors
TORONTO, ONTARIO--(Marketwired - Dec 5, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT) (OTCQX:EDTXF) a Phase III company developing the first treatment for patients with endotoxemic septic shock using a medical …